A previous study revealed an important mechanism that regulates the stability and enzymatic activity of PDHA1 and ACAT1 in cells via UBE3A-mediated ubiquitination, regulating glycolysis and lipid metabolism in the NAFLD process, and contributing to the onset and progression of NAFLD (124). Here, UBE3A is linked to metabolic dysfunction-associated steatotic liver disease.